Unravelling the causal relationship between endometriosis and the risk for developing venous thromboembolism: a pooled analysis.


Journal

Thrombosis and haemostasis
ISSN: 2567-689X
Titre abrégé: Thromb Haemost
Pays: Germany
ID NLM: 7608063

Informations de publication

Date de publication:
02 Sep 2024
Historique:
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 2 9 2024
Statut: aheadofprint

Résumé

To investigate the effect of endometriosis on Venous Thromboembolism (VTE) in Oral Contraceptives (OCs) users. Pooled analysis on a harmonized dataset compromising international patient-centric cohort studies: INAS-VIPOS, INAS-SCORE, and INAS-FOCUS. 11 European countries, the US, and Canada Population: Individuals being newly prescribed an OC with or without an endometriosis and no VTE history. Detailed information was captured using self-administered questionnaires at baseline and every 6-12 months thereafter. Self-reported VTEs were medically validated and reviewed by an independent adjudication committee. Incidence rates (IR) were calculated per 10,000 woman-years. The association of endometriosis on VTE was determined in a time-to-event analysis, calculating crude and adjusted Hazard Ratios (HRs) with 95% confidence intervals (CI) using stabilized inverse probability of treatment weighting (IPTW). A total of 22,072 women had an endometriosis diagnosis, and 91,056 women did not. Women with endometriosis contributed 78,751 woman-years during which 41 VTE events occurred (IR: 5.2/10,000, 95% CI: 3.7-7.1) compared to 127 VTEs during 310,501 woman-years in women without endometriosis (IR 4.1/10,000, 95% CI: 3.4-4.9). The HR of VTE in women with endometriosis was 1.79 (95% CI: 1.24-2.57) using stabilized IPTW controlling for age, BMI, smoking, education, age at menarche, and family history of VTE. Subgroup and sensitivity analyses showed similar results. These results highlight the importance of considering endometriosis as a potential factor contributing to VTE in women using OC however, further research on the relationship between endometriosis and VTE is warranted. No funding. Endometriosis, Venous Thromboembolism.

Identifiants

pubmed: 39222924
doi: 10.1055/a-2407-9498
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Pauline De Corte (P)

ZEG - Berlin Center for Epidemiology and Health Research GmbH, Berlin, Germany.
Charite Universitatsmedizin Berlin, Berlin, Germany.

Igor Milhoranca (I)

ZEG - Berlin Center for Epidemiology and Health Research GmbH, Berlin, Germany.

Sylvia Mechsner (S)

Endometriosis Centre Charité, Department of Gynaecology, Charite Universitatsmedizin Berlin, Berlin, Germany.

Sara Anna Öberg (SA)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Tobias Kurth (T)

Charité University Hospital Berlin Institute of Public Health, Berlin, Germany.

Klaas Heinemann (K)

ZEG - Berlin Center for Epidemiology and Health Research GmbH, Berlin, Germany.

Classifications MeSH